Augustine secures $85m to advance Charcot-Marie-Tooth candidate [Yahoo! Finance]
Tenaya Therapeutics, Inc. (TNYA)
Company Research
Source: Yahoo! Finance
Novo Holdings and Jeito Capital co-led the $85m round, with participation from Asabys Partners, Eli Lilly, AdBio partners, V-Bio Ventures, PMV, VIB, Gemma Frisius Fund, the US-based CMT Research Foundation and Newton Biocapital. This follows an initial €17.5m round led by Asabys Partners in July 2024. The new funding will primarily support the clinical advancement of Augustine's lead candidate, AGT-100216. Augustine's approach focuses on inhibiting the cytosolic histone deacetylase 6 (HDAC6) enzyme, which plays a key role in neurodegeneration and aging-related cellular processes. The company's scientific foundation is based on the research of Professor Ludo Van Den Bosch from the VIB-KU Leuven Center for Brain and Disease Research,
Read more
Impact Snapshot
Event Time:
TNYA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TNYA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TNYA alerts
High impacting Tenaya Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TNYA
News
- Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy ModelsGlobeNewswire
- Tenaya Therapeutics, Inc. (TNYA) Stock [Seeking Alpha]Seeking Alpha
- Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College of Cardiology’s Annual Scientific SessionGlobeNewswire
- Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $18.00 to $6.00. They now have a "buy" rating on the stock.MarketBeat
- Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its price target lowered by analysts at Morgan Stanley from $15.00 to $5.00. They now have an "overweight" rating on the stock.MarketBeat
TNYA
Earnings
- 5/14/24 - Beat
TNYA
Sec Filings
- 3/28/25 - Form 8-K
- 3/21/25 - Form S-3
- 3/10/25 - Form 4
- TNYA's page on the SEC website